Relationship between CD33 expression, splicing polymorphism, and in vitro cytotoxicity of gemtuzumab ozogamicin and the CD33/CD3 BiTE® AMG 330

• George S. Laszlo,
• Mary E. Beddoe,
• Colin D. Godwin,
• Olivia M. Bates,
• Chelsea J. Gudgeon,
• Kimberly H. Harrington,
• Roland B. Walter

Affiliations

George S. Laszlo

Clinical Research Division, Fred Hutchinson Cancer Research Center

Mary E. Beddoe

Clinical Research Division, Fred Hutchinson Cancer Research Center

Colin D. Godwin

Hematology/Oncology Fellowship Program

Olivia M. Bates

Clinical Research Division, Fred Hutchinson Cancer Research Center

Chelsea J. Gudgeon

Clinical Research Division, Fred Hutchinson Cancer Research Center

Kimberly H. Harrington

Clinical Research Division, Fred Hutchinson Cancer Research Center

Roland B. Walter

Hematology/Oncology Fellowship Program;Department of Medicine, Division of Hematology;Department of Epidemiology, University of Washington, Seattle, WA, USA